The impact of border crossing and imprisonment on injection practices and risk of HIV and hepatitis C infection among men who inject drugs in Nepal

被引:0
|
作者
Zaccheo, Sonia K. [1 ,4 ]
Marrone, Gaetano [1 ]
Pandey, Lok Raj [2 ]
Deuba, Keshab [1 ,3 ]
机构
[1] Karolinska Inst, Dept Global Publ Hlth, SE-17177 Stockholm, Sweden
[2] Natl Ctr AIDS & STD Control NCASC, Minist Hlth & Populat, Kathmandu, Nepal
[3] Natl Ctr AIDS & STD Control NCASC, Global Fund Programs, Kathmandu, Nepal
[4] Georg August Univ, Univ Med Gottingen UMG, Fac Med, Gottingen, Germany
关键词
HIV; Hepatitis C virus; Injection drug use; Border crossing; Imprisonment; Risk behavior; PEOPLE; USERS; TRANSMISSION; PREVALENCE; HEALTH; VIRUS; CHINA; BIAS; INCARCERATION; BALTIMORE;
D O I
10.1016/j.drugpo.2023.104145
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: In Nepal, personal drug use is criminalized and among people who inject drugs (PWID), the majority of whom are men, movement across the border with India for drug procurement and use is common. Using a risk environment approach, this study examined associations between border crossing and imprisonment with respect to HIV, HCV and injection risk behavior among men who inject drugs in Nepal.Methods: This cross-sectional study analyzed data from 1345 participants from 14 districts across Nepal. Explanatory variables were prior imprisonment and past-month border crossing to procure or use drugs. We used multivariable logistic regression to evaluate associations between these variables and HIV, HCV, HIV/HCV co infection and past-month injection risk behavior among PWID. Results: Over half of participants reported prior imprisonment (34.6% prior to past year, 21.6% within past year) and Indo-Nepal border crossing in the past year to use or buy drugs (31.2% sometimes, 20.8% often); over one quarter of participants (29.6%) reported both. Imprisonment prior to the past year was associated with higher odds of all outcome variables: HIV (adjusted odds ratio (aOR) 2.44, 95% confidence interval (CI) 1.29-4.59), HCV (aOR 1.51, 95% CI 1.08-2.09), HIV/HCV co-infection (aOR 3.12, 95% CI 1.58-6.14) and injection risk behavior (aOR 1.64, 95% CI 1.20-2.25). Past-year border crossing to procure or use drugs was associated with HCV (aOR 2.06, 95% CI 1.42-2.98) and injection risk behavior (aOR 1.47, 95% CI 1.04-2.10), with larger effect sizes among PWID who reported both border crossing as well as history of imprisonment.Conclusion: Imprisonment and border crossing were associated with injection risk behavior and disease outcomes. These findings indicate a need to implement cross-border disease surveillance and harm reduction initiatives in the Indo-Nepal border region and in Nepali prisons.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?
    Perlman, David C.
    Des Jarlais, Don C.
    Feelemyer, Jonathan
    JOURNAL OF ADDICTIVE DISEASES, 2015, 34 (2-3) : 198 - 205
  • [2] Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs
    Hope, Vivian D.
    McVeigh, James
    Begley, Emma
    Glass, Rachel
    Edmundson, Claire
    Heinsbroek, Ellen
    Kean, Joseph
    Campbell, John
    Whitfield, Mark
    Morgan, Gareth
    Acreman, Dean
    Smith, Josie
    DRUG AND ALCOHOL REVIEW, 2021, 40 (04) : 586 - 596
  • [3] Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection
    Artenie, Andreea Adelina
    Hickman, Matthew
    Vickerman, Peter
    Stone, Jack
    Grebely, Jason
    Bruneau, Julie
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 96
  • [4] Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California
    Horyniak, Danielle
    Wagner, Karla D.
    Armenta, Richard E.
    Cuevas-Mota, Jazmine
    Hendrickson, Erik
    Garfein, Richard S.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 9 - 17
  • [5] Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China
    Fang, Kailu
    Wang, Hong-liang
    Lin, Yushi
    Li, Shuwen
    Wu, Jie
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (04) : 1043 - 1055
  • [6] Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore
    Hackman, Jada
    Falade-Nwulia, Oluwaseun
    Patel, Eshan U.
    Mehta, Shruti H.
    Kirk, Gregory D.
    Astemborski, Jacquie
    Ray, Stuart C.
    Thomas, David L.
    Laeyendecker, Oliver
    INFECTION GENETICS AND EVOLUTION, 2020, 77
  • [7] Unsafe injecting practices, sexual risk behaviours and determinants of HIV among men who inject drugs: Results from Integrated Biological and Behavioural Surveillance in India
    Kumar, Pradeep
    Sangal, Bhavna
    Ramanathan, Shreena
    Ammassari, Savina
    Venkatesh, Srinivasa Raghavan
    INTERNATIONAL JOURNAL OF STD & AIDS, 2018, 29 (11) : 1066 - 1075
  • [8] Policing Practices and Risk of HIV Infection Among People Who Inject Drugs
    Baker, Pieter
    Beletsky, Leo
    Avalos, Liliana
    Venegas, Christopher
    Rivera, Carlos
    Strathdee, Steffanie A.
    Cepeda, Javier
    EPIDEMIOLOGIC REVIEWS, 2020, 42 (01) : 27 - 40
  • [9] HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming
    Baluku, Matayo
    Wamala, Twaibu
    Muhangi, Denis
    HARM REDUCTION JOURNAL, 2019, 16 (01)
  • [10] History of detention and the risk of hepatitis C among people who inject drugs in Germany
    Gassowski, Martyna
    Nielsen, Stine
    Bannert, Norbert
    Bock, Claus-Thomas
    Bremer, Viviane
    Ross, R. Stefan
    Wenz, Benjamin
    Marcus, Ulrich
    Zimmermann, Ruth
    Hecht, Andreas
    Heinz, Werner
    Klee, Juergen
    Leicht, Astrid
    Scherbaum, Norbert
    Schaeffer, Dirk
    Santos-Hoevener, Claudia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 81 : 100 - 106